2026 NPPES data Hematology & Oncology Physician NPI 1396013363 MD
Verify on CMS →

NAVEEN YARLAGADDA, MD

Hematology & Oncology Physician in LITTLE ROCK, Arkansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
790
Medicare Part D claims · 171 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$3.1K
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: NAVEEN YARLAGADDA, MD is a Hematology & Oncology Physician ([object Object]) practicing in LITTLE ROCK, Arkansas with a Medicare Part D prescribing footprint of 790 claims across 171 beneficiaries — 14% brand-name prescribing . Industry payments of $3.1K across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: NAVEEN YARLAGADDA, MD filed 790 Medicare Part D claims in 2023 across LITTLE ROCK, Arkansas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

NAVEEN YARLAGADDA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

NAVEEN YARLAGADDA, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 12/06/2011

NPI 1396013363

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

790 7% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Arkansas

How Hematology & Oncology Physician compares to other specialties among Arkansas providers

Arkansas providers

Hematology & Oncology Physician share within Arkansas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Arkansas

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAVEEN YARLAGADDA, MD is a Hematology & Oncology Physician provider practicing in LITTLE ROCK, Arkansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1396013363. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NAVEEN YARLAGADDA, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 8901 CARTI WAY, LITTLE ROCK, AR, 72205, with a listed phone of (501) 906-3000. NPI 1396013363 was issued on 12/06/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what YARLAGADDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 790 prescription claims written by this provider, covering 171 Medicare beneficiaries and totaling roughly $500K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 13.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8901 CARTI WAY
LITTLE ROCK, AR 72205

Provider Details

NPI 1396013363
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 12/06/2011

Hospital and facility affiliations

Facilities where NAVEEN YARLAGADDA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ARKANSAS HEALTH GROUP
NORTH LITTLE ROCK, AR
CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE INC
LITTLE ROCK, AR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAVEEN YARLAGADDA, MD. Source: openpaymentsdata.cms.gov.

Total received

$3.1K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

NAVEEN YARLAGADDA, MD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 790 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

790
Total Claims
$500K
Total Drug Cost
171
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
937
Total Day Supply
23,584
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$453K
Generic Drug Cost
$48K
Opioid Claims
103 (13.0% rate)
Antibiotic Claims
40

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
2.17
Gender Split
56% female / 44% male
Age Distribution
<65: 31, 65-74: 80, 75-84: 49, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ondansetron Odt
Ondansetron
56
Prochlorperazine Maleate
43
Oxycodone Hcl
42
Eliquis
Apixaban
38
Acyclovir
34
Prednisone
34
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
31
Hydroxyurea
31
Pantoprazole Sodium
28
Potassium Chloride
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NAVEEN YARLAGADDA, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NAVEEN YARLAGADDA, MD's 790 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Arkansas

Other clinicians with the same primary specialty enrolled in Arkansas, drawn from the same CMS NPPES roster as YARLAGADDA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAVEEN YARLAGADDA, MD's specialty?
NAVEEN YARLAGADDA, MD specializes in Hematology & Oncology Physician and practices in LITTLE ROCK, Arkansas. Credentials: MD.
How much does NAVEEN YARLAGADDA, MD prescribe under Medicare Part D?
In 2023, NAVEEN YARLAGADDA, MD wrote 790 Medicare Part D claims totaling $500K in drug costs for 171 beneficiaries.
Where is NAVEEN YARLAGADDA, MD located?
NAVEEN YARLAGADDA, MD is located at 8901 CARTI WAY, LITTLE ROCK, AR, 72205. Phone: (501) 906-3000.
What is NAVEEN YARLAGADDA, MD's NPI number?
NAVEEN YARLAGADDA, MD's National Provider Identifier (NPI) is 1396013363, issued on 12/06/2011.
Does NAVEEN YARLAGADDA, MD prescribe more brand-name or generic drugs?
NAVEEN YARLAGADDA, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $453K in brand drug costs.
Does NAVEEN YARLAGADDA, MD prescribe opioids?
Yes, NAVEEN YARLAGADDA, MD had 103 opioid claims in 2023 with an opioid prescribing rate of 13.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NAVEEN YARLAGADDA, MD prescribe most often?
Based on 2023 Medicare Part D data, NAVEEN YARLAGADDA, MD's most frequently prescribed drugs include Ondansetron Odt, Prochlorperazine Maleate, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAVEEN YARLAGADDA, MD accept Medicare?
NAVEEN YARLAGADDA, MD appears in CMS Medicare data with 790 Part D claims and 171 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAVEEN YARLAGADDA, MD's credentials?
NAVEEN YARLAGADDA, MD's NPI is 1396013363 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology